J. Belinson

发表

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.

M Markman, Yan Xu, G. Casey, 1998, JAMA.

Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.

G. Casey, Y. Xu, P. Elson, 2001, Gynecologic oncology.

CCL 2 Expression in Primary Ovarian Carcinoma Is Correlated with Chemotherapy Response and Survival Outcomes

R. Ganapathi, P. Elson, A. Fader, 2010 .

Patient callback program: a quality improvement, customer service, and marketing tool.

P. Miller, W. Gombeski, J. Belinson, 1993, Journal of health care marketing.

Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers

M. Markman, J. Belinson, K. Webster, 2004, Journal of Cancer Research and Clinical Oncology.

Carboplatin plus paclitaxel combination chemotherapy: impact of sequence of drug administration on treatment-induced neutropenia.

P. Elson, M. Markman, J. Belinson, 2003, Gynecologic oncology.

Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum- and paclitaxel-refractory ovarian cancer.

M. Markman, A. Kennedy, J. Belinson, 2000, Gynecologic oncology.

Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse.

Y. Qiao, Xun Zhang, J. Belinson, 2004, American journal of obstetrics and gynecology.

Unfolding the pathophysiological role of bioactive lysophospholipids.

P. Elson, M. Markman, L. Baudhuin, 2003, Current drug targets. Immune, endocrine and metabolic disorders.

Examples of the marked variability in the relationship between the serum CA-125 antigen level and cancer-related symptoms in ovarian cancer.

M. Markman, J. Belinson, K. Webster, 2004, Gynecologic oncology.

Looking ahead: A case for human papillomavirus testing of self‐sampled vaginal specimens as a cervical cancer screening strategy

K. Shah, J. Salmerón, P. Gravitt, 2011, International journal of cancer.

Inflation of Sensitivity of Cervical Cancer Screening Tests Secondary to Correlated Error in Colposcopy

Y. Qiao, P. Elson, J. Belinson, 2006, Journal of lower genital tract disease.

Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer.

M. Markman, J. Belinson, K. Webster, 2003, Gynecologic oncology.

Utility of Random Cervical Biopsy and Endocervical Curettage in a Low-Risk Population

Suzanne Belinson, J. Belinson, Jerome L Belinson, 2012, Journal of lower genital tract disease.

Loop Electrosurgical Excision Procedure or Cervical Conization to Exclude Cervical Cancer Before Simple Hysterectomy

J. Belinson, R. Pretorius, Patricia Peterson, 2020, Journal of lower genital tract disease.

High-Grade Cervical Intraepithelial Neoplasia Detected by Colposcopy-Directed or Random Biopsy Relative to Age, Cytology, Human Papillomavirus 16, and Lesion Size

Bin Yang, J. Belinson, R. Pretorius, 2016, Journal of lower genital tract disease.

A Standard Protocol for the Colposcopy Exam.

J. Belinson, R. Pretorius, 2016, Journal of lower genital tract disease.

Which Colposcopies Should Include Endocervical Curettage?

R. Burchette, J. Belinson, R. Pretorius, 2015, Journal of lower genital tract disease.

Shanxi Province cervical cancer screening study II: Self‐sampling for high‐risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology

Y. Qiao, J. Belinson, F. Zhao, 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Regardless of Skill, Performing More Biopsies Increases the Sensitivity of Colposcopy

Y. Qiao, R. Burchette, Xun Zhang, 2011, Journal of lower genital tract disease.

Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology

Y. Qiao, J. Belinson, F. Zhao, 2003, International Journal of Gynecologic Cancer.

OCT in Gynecology

V. Gelikonov, F. Feldchtein, N. Gladkova, 2008 .

The effect of radiation therapy on brain metastases from endometrial carcinoma: a retrospective study.

G. Barnett, J. Suh, J. Belinson, 2001, Gynecologic oncology.

Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.

A. Fader, P. Rose, M. Markman, 2008, Gynecologic oncology.

Erratum: "Shanxi Province Cervical Cancer Screening Study: A Cross-Sectional Comparative Trial of Multiple Techniques to Detect Cervical Neoplasia," (Gynecologic Oncology (2001) 83:2(439-444)

Y. Qiao, D. Zahniser, P. Elson, 2002 .

Prevalence of Human Papillomavirus Among Chinese Han and Mongols Minority Women in Inner Mongolia, China: Reflected by Self-Collected Samples in CHIMUST

Chao Zhao, J. Belinson, C. Guo, 2022, Frontiers in Public Health.

Clinical stage I adenocarcinoma of the endometrium--analysis of recurrences and the potential benefit of staging lymphadenectomy.

G. Badger, J. Belinson, Kenneth R. Lee, 1992, Gynecologic oncology.

Vaginal ultrasonography versus endometrial biopsy in women with postmenopausal bleeding.

A. Weber, M. Piedmonte, J. Belinson, 1997, American journal of obstetrics and gynecology.

Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma.

P. Vacek, J. Belinson, Kenneth R. Lee, 1994, Gynecologic oncology.

Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy.

M. Markman, J. Belinson, K. Webster, 2004, Gynecologic oncology.

Inappropriate gold standard bias in cervical cancer screening studies

Y. Qiao, Jennifer S. Smith, R. Burchette, 2007, International journal of cancer.

Serum CA-125 measurements > 65 U/mL. Clinical value.

L. Blumenson, J. Belinson, G. Eltabbakh, 1997, The Journal of reproductive medicine.

Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.

M. Markman, J. Belinson, K. Webster, 2004, Gynecologic oncology.

Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions

M. Markman, J. Belinson, K. Webster, 2003, Journal of Cancer Research and Clinical Oncology.

Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer.

A. Kennedy, J. Belinson, K. Webster, 1999, Gynecologic oncology.

Evidence that a “treatment-free interval of less than 6 months” does not equate with clinically defined platinum resistance in ovarian cancer or primary peritoneal carcinoma

M. Markman, J. Belinson, A. Kennedy, 1998, Journal of Cancer Research and Clinical Oncology.

Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.

G. Sutton, M. Markman, J. Hurteau, 1998, Gynecologic oncology.

Continued chemosensitivity to cisplatin/carboplatin in ovarian carcinoma despite treatment with multiple prior platinum-based regimens.

M. Markman, A. Kennedy, J. Belinson, 1997, Gynecologic oncology.

Evaluating the Performance of p16INK4a Immunocytochemistry in Cervical Cancer Screening

J. Belinson, H. Du, Chun Wang, 2020, Cancer management and research.

The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples

Lihui Wei, Yan Liu, J. Belinson, 2020, PloS one.

Introduction of human papillomavirus DNA screening in the world: 15 years of experience.

Y. Qiao, S. de Sanjosé, P. Castle, 2012, Vaccine.

Cervical Screening by Pap Test and Visual Inspection Enabling Same-Day Biopsy in Low-Resource, High-Risk Communities.

J. Belinson, R. Pretorius, X. Qu, 2019, Obstetrics and gynecology.

Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population‐based studies

S. Franceschi, Y. Qiao, Jennifer S. Smith, 2012, International journal of cancer.

Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.

S. Franceschi, Y. Qiao, P. Castle, 2010, The Lancet. Oncology.

Prevalence of type‐specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self‐collected specimens: Implications for vaginal self‐collection

Y. Qiao, Jennifer S. Smith, R. Burchette, 2009, International journal of cancer.

Evaluation of Cobas HPV and SeqHPV Assays in the Chinese Multicenter Screening Trial

Lihui Wei, Yan Liu, Chao Zhao, 2021, Journal of lower genital tract disease.

Mexican Cervical Cancer Screening Study II: Acceptability of Human Papillomavirus Self-Sampler

J. Belinson, S. Belinson, Lucybeth Nieves Arriba, 2010, International Journal of Gynecologic Cancer.

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China.

Y. Qiao, Jennifer S. Smith, W. Xiang, 2009, American journal of epidemiology.

Primary Screening with Liquid-Based Cytology in an Unscreened Population in Rural China, with an Emphasis on Reprocessing Unsatisfactory Samples

Y. Qiao, P. Elson, C. Biscotti, 2002, Acta Cytologica.

Community Health Workers, Social Support and Cervical Cancer Screening among High-risk Groups in Rural Mexico

K. Smyth, E. Ottolenghi, J. Belinson, 2013, Journal of health care for the poor and underserved.

Phase 2 Trial of Interferon-Beta as Second-Line Treatment of Ovarian Cancer, Fallopian Tube Cancer, or Primary Carcinoma of the Peritoneum

E. Borden, B. Jacobs, D. Lindner, 2004, Oncology.

Phase 2 trial of carboplatin plus tamoxifen in platinum-resistant ovarian cancer and primary carcinoma of the peritoneum.

M. Markman, J. Belinson, K. Webster, 2004, Gynecologic oncology.

Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials.

M. Markman, J. Belinson, K. Webster, 2004, Gynecologic oncology.

Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers.

P. Escobar, P. Rose, M. Markman, 2004, Gynecologic oncology.

Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum.

M. Markman, J. Belinson, K. Webster, 2003, Gynecologic oncology.

Combination chemotherapy with carboplatin and docetaxel in the treatment of cancers of the ovary and fallopian tube and primary carcinoma of the peritoneum.

M. Markman, A. Kennedy, J. Belinson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of paclitaxel plus megestrol acetate in patients with paclitaxel-refractory ovarian cancer.

M. Markman, A. Kennedy, J. Belinson, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Paclitaxel-Assoc iated H ypersensitivity R eactions: Experience o f t he G ynecologic O ncology P rogram o f t he Cleveland C linic C ancer C enter

M. Markman, J. Belinson, A. Kennedy, 2000 .

Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center.

M. Markman, A. Kennedy, J. Belinson, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum.

M. Markman, A. Kennedy, J. Belinson, 2000, Gynecologic oncology.

Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens.

P. Rose, I. Horowitz, W. Mcguire, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paclitaxel administration to gynecologic cancer patients with major cardiac risk factors.

A. Kennedy, J. Belinson, K. Webster, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum.

L. Rybicki, M. Markman, J. Belinson, 1998, Gynecologic oncology.

Phase 2 trial of moderately high dose single agent mitoxantrone in platinum and paclitaxel-refractory ovarian cancer.

S. Lichtman, H. Homesley, G. Omura, 1998, Gynecologic oncology.

False‐Negative Peritoneal Cytology in Metastatic Ovarian Carcinoma

J. Belinson, Kenneth R. Lee, K. Lee, 1986, Obstetrics and gynecology.

Population‐based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women

Y. Qiao, Jennifer S. Smith, M. Esser, 2012, International journal of cancer.

Factors That Virtually Exclude Cervical Cancer at Colposcopy

R. Burchette, J. Belinson, R. Pretorius, 2015, Journal of lower genital tract disease.

Radical hysterectomy for cervical cancer: the effect of shorter length of stay on outcome.

L. Tuason, J. Belinson, A. Kennedy, 1995, Cleveland Clinic journal of medicine.

Optical diagnosis of cervical dysplasia

P. Escobar, J. Belinson, L. Rojas-Espaillat, 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Empowering Low-Income Asian American Women to Conduct Human Papillomavirus Self-Sampling Test: A Community-Engaged and Culturally Tailored Intervention

C. Fang, G. Ma, Yin Tan, 2022, Cancer control : journal of the Moffitt Cancer Center.

Descriptive Evidence That Risk Profiles for Cervical Intraepithelial Neoplasia 1, 2, and 3 Are Unique

A. Olshan, Y. Qiao, E. Myers, 2008, Cancer Epidemiology Biomarkers & Prevention.

Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.

M. Markman, D. Uyar, J. Belinson, 2004, Gynecologic oncology.

The familial ovarian cancer registry: progress report.

G. Casey, J. Belinson, W. R. Hart, 1995, Cleveland Clinic journal of medicine.

The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer

Lihui Wei, Yan Liu, J. Belinson, 2020, PloS one.

A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study.

Y. Liu, Bin Yang, J. Belinson, 2011, American journal of clinical pathology.

Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.

Y. Xu, Yan Xu, Z. Shen, 1998, Gynecologic oncology.

Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States

N. Brewer, A. Deal, Jennifer S. Smith, 2017, Sexually transmitted diseases.

Management of epithelial ovarian neoplasms using a platinum-based regimen: a 10-year experience.

K. R. Lee, J. Belinson, Kenneth R. Lee, 1990 .

Recommendations for screening and early detection of common cancers in India.

Anurag Srivastava, Sudha Sivaram, Preetha Rajaraman, 2015, The Lancet. Oncology.

A Pilot Study to Evaluate an Internet-Based Cervical Cancer Screening Model Based on Self-Sampling

R. Wu, J. Belinson, H. Du, 2016 .

Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.

M. Markman, J. Belinson, K. Webster, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy.

L. Rybicki, M. Markman, J. Belinson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Control of carboplatin-induced emesis with a fixed low dose of granisetron (0.5 mg) plus dexamethasone.

M. Markman, A. Kennedy, J. Belinson, 1996, Gynecologic oncology.

Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer

P. Escobar, M. Markman, J. Belinson, 2003, Journal of Cancer Research and Clinical Oncology.

Key Determinants of the Value of Random Cervical Biopsy at Colposcopy.

Y. Qiao, R. Burchette, J. Belinson, 2019, Journal of lower genital tract disease.

p16 Immunohistochemistry in Colposcope-Directed and Random Cervical Biopsies of CIN2 and CIN3

Bin Yang, J. Belinson, R. Pretorius, 2016, Journal of lower genital tract disease.

The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy.

M. Markman, A. Kennedy, J. Belinson, 2000, Gynecologic oncology.

Low-dose oral granisetron (1 mg) plus intravenous dexamethasone: efficacy in gynecologic cancer patients receiving carboplatin-based chemotherapy.

M. Markman, A. Kennedy, J. Belinson, 1998, Gynecologic oncology.

Second-line therapy of ovarian cancer with Paclitaxel administered by both the intravenous and intraperitoneal routes: rationale and case reports.

M. Markman, J. Belinson, A. Kennedy, 2002, Gynecologic oncology.

Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity.

M. Markman, A. Kennedy, J. Belinson, 1996, Gynecologic oncology.

p53 and HER-2/neu overexpression in ovarian borderline tumors.

G. Casey, R. Tubbs, C. Biscotti, 1997, Gynecologic oncology.

A rationale for neoadjuvant systemic treatment followed by surgical assessment and intraperitoneal chemotherapy in patients presenting with non-surgically resectable ovarian or primary peritoneal cancers

M. Markman, J. Belinson, 2004, Journal of Cancer Research and Clinical Oncology.

Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes.

A. Fader, C. Michener, J. Belinson, 2009, Journal of minimally invasive gynecology.

Clinical features of hypersensitivity reactions to carboplatin.

P. Elson, A. Kennedy, J. Belinson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of exploratory celiotomy on the management of carcinoma of the cervix. A preliminary report

J. Belinson, J. Ford, A. Sudarsanam, 1978, Cancer.

Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma.

P. Rose, C. Kunos, J. Belinson, 2009, American journal of obstetrics and gynecology.

Papillary serous adenocarcinoma of the endometrium: a clinicopathologic study of 19 cases.

J. Belinson, Kenneth R. Lee, K. Lee, 1992, Gynecologic oncology.

Salvage therapy for recurrent and refractory ovarian cancer with high-dose chemotherapy and autologous bone marrow support: a Gynecologic Oncology Group pilot study.

J. Berek, D. Hurd, E. R. Broun, 1994, Gynecologic oncology.

Experience with prophylactic oral ciprofloxacin in gynecological cancer patients developing severe chemotherapy-induced neutropenia

M. Markman, J. Belinson, A. Kennedy, 2000, Journal of Cancer Research and Clinical Oncology.

Recurrence in Noninvasive Endometrial Carcinoma: Relationship to Uterine Papillary Serous Carcinoma Kenneth R. Lee, M.D.,

J. Belinson, 1991, The American journal of surgical pathology.

Combination chemotherapy of ovarian carcinoma with CAP

J. Belinson, J. P. Griffin, J. Lynn, 1981 .

Palliative benefit of radiation therapy in advanced ovarian cancer.

J. Belinson, L. May, T. Roland, 1990, Gynecologic oncology.

Primary clear cell carcinoma of the peritoneum.

J. Belinson, K. Lee, U. Verma, 1991, Gynecologic oncology.

Are screen-and-treat approaches effective for cervical cancer prevention?

J. Belinson, 2006, Nature Clinical Practice Oncology.

Mexican Cervical Cancer Screening Study II: 6-Month and 2-Year Follow-up of HR-HPV Women Treated With Cryotherapy in a Low-Resource Setting

J. Belinson, A. Chiesa-Vottero, J. Brainard, 2014, Journal of lower genital tract disease.

Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias.

M. Markman, A. Kennedy, J. Belinson, 1999, Gynecologic oncology.

Neurotoxicity associated with a regimen of carboplatin (AUC 5–6) and paclitaxel (175 mg/m2 over 3 h) employed in the treatment of gynecologic malignancies

M. Markman, J. Belinson, A. Kennedy, 2001, Journal of Cancer Research and Clinical Oncology.

Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature.

T. Mekhail, J. Belinson, R. Kim, 2006, Gynecologic oncology.

Thermocoagulation versus cryotherapy for the treatment of cervical precancers

J. Belinson, H. Du, Chun Wang, 2020, The journal of obstetrics and gynaecology research.

Expanded E xperience W ith a n I ntradermal S kin T est t o Predict f or t he P resence o r A bsence o f C arboplatin Hypersensitivity

M. Markman, J. Belinson, K. Webster, 2003 .

Six-Year Regression and Progression of Cervical Lesions of Different Human Papillomavirus Viral Loads in Varied Histological Diagnoses

D. Colombara, Y. Qiao, Jennifer S. Smith, 2013, International Journal of Gynecologic Cancer.

CMAR_A_273079 9067..9075

J. Belinson, H. Du, Chun Wang, 2020 .

Gastrointestinal toxicity is not a major complication of standard dose paclitaxel therapy.

M. Markman, A. Kennedy, J. Belinson, 1999, Gynecologic oncology.

Clinical F eatures o f H ypersensitivity Reactions t o C arboplatin

P. Elson, M. Markman, J. Belinson, 1999 .

A new PCR-based mass spectrometry system for high-risk HPV, part II: clinical trial.

X. Yi, Bin Yang, J. Belinson, 2011, American journal of clinical pathology.

CASE REPORT Primary Clear Cell Carcinoma of the Peritoneum

J. Belinson, Kenneth R. Lee, U. Verma, 1991 .

The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?

P. Elson, R. Burchette, J. Belinson, 2001, The Journal of reproductive medicine.

Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.

L. Rybicki, D. Kushner, M. Markman, 2000, Gynecologic oncology.

Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors.

G. Casey, J. Belinson, W. R. Hart, 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Squamous cell carcinoma of the cervix: HPV 16 and DNA ploidy as predictors of survival.

G. Badger, N. Heintz, C. Collins, 1992, Gynecologic oncology.

The prevalence and distribution of human papillomavirus among 10,867 Chinese Han women

J. Belinson, C. Guo, H. Du, 2020, Infectious agents and cancer.

Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids.

Yan Xu, Y. Xu, B. Schwartz, 2001, Analytical biochemistry.

Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical cancer: a review.

J. Belinson, Jerome L Belinson, Sarah K Goodrich, 2014, Future oncology.

Development and validation of a new HPV genotyping assay based on next-generation sequencing.

X. Yi, Xifang Nie, Bin Yang, 2014, American journal of clinical pathology.

A new technique for ovarian transposition.

J. Belinson, J. McDay, M. Doherty, 1984, Surgery, gynecology & obstetrics.

The Peru Cervical Cancer Screening Study (PERCAPS): The Design and Implementation of a Mother/Daughter Screen, Treat, and Vaccinate Program in the Peruvian Jungle

J. Salmerón, K. Levinson, Carolina Abuelo, 2014, Journal of Community Health.

Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.

G. Casey, D. Wiper, J. Belinson, 1998, Gynecologic oncology.

False negative colposcopy is associated with thinner cervical intraepithelial neoplasia 2 and 3.

Y. Qiao, Bin Yang, R. Burchette, 2008, Gynecologic oncology.

Distribution of Cervical Intraepithelial Neoplasia 2, 3 and Cancer on the Uterine Cervix

Y. Qiao, Xun Zhang, J. Belinson, 2006, Journal of lower genital tract disease.

Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.

Y. Qiao, D. Zahniser, P. Elson, 2001, Gynecologic oncology.

Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion

Yan Xu, Wenliang Li, W. Li, 2007, Oncogene.

Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.

S. Mok, Y. Kwak, Samuel C Mok, 2006, Cancer research.

p53 overexpression is Not an independent prognostic factor for patients with primary ovarian epithelial cancer

G. Casey, L. Blumenson, R. Tubbs, 1997, Cancer.

CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes.

R. Ganapathi, P. Elson, A. Fader, 2010, Anticancer research.

Gynecologic History of Women With Inflammatory Bowel Disease

A. Weber, A. Mitchinson, J. Belinson, 1995, Obstetrics and gynecology.

Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design.

M. Markman, J. Belinson, K. Webster, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grades 1 or worse among 4215 Chinese women in a population-based study.

Y. Qiao, Xun Zhang, Wen Chen, 2013, Cancer epidemiology.

Treatment of gynecologic cancers in pregnancy.

J. Belinson, A. Kennedy, K. Zanotti, 2000, Seminars in oncology.

Declining CA-125 in an ovarian cancer patient with progression of measurable disease: a rational hypothesis for discordant results.

M. Markman, A. Kennedy, J. Belinson, 2000, Gynecologic oncology.

Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study

Y. Qiao, Jennifer S. Smith, Jian-bing Wang, 2013, Cancer Causes & Control.

Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.

Y. Qiao, Hao Liang, J. Belinson, 2009, Vaccine.

Medical and osteopathic boards' positions on chaperones during gynecologic examinations.

J. Belinson, S. Stagno, H. Forster, 1999, Obstetrics and gynecology.

Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI‐MS) Analyses

Y Chen, Yan Xu, J Belinson, 2000, Annals of the New York Academy of Sciences.

University of Groningen Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population

E. Schuuring, H. Klip, G. Wisman, 2018 .

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off

E. Schuuring, A. V. D. Van Der Zee, H. Klip, 2014, PloS one.

Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.

G. Badger, J. Belinson, M. Mcclure, 1987, Gynecologic oncology.

Hexamethylmelamine, methotrexate, 5-fluorouracil as second line chemotherapy after platinum for epithelial ovarian malignancies.

T. Ashikaga, J. Belinson, R. Pretorius, 1986, Gynecologic oncology.

Stage I carcinoma of the endometrium: a 5-year experience utilizing preoperative cesium.

G. Badger, J. Belinson, R. Pretorius, 1985, Gynecologic oncology.

An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media

J. Belinson, K. Maurer, H. Du, 2016, PloS one.

Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women

Y. Qiao, Jennifer S. Smith, M. Esser, 2012, BMC Infectious Diseases.

Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial

A. Joseph, R. Vogel, K. Okuyemi, 2015, Cancer medicine.

Prevalence and sociodemographic correlates of cervicovaginal human papillomavirus (HPV) carriage in a cross-sectional, multiethnic, community-based female Asian population

S. Subramaniam, Y. Woo, P. Goh, 2017, Sexually Transmitted Infections.

A Thin-Layer, Liquid-Based Pap Test for Mass Screening in an Area of China with a High Incidence of Cervical Carcinoma

Y. Qiao, Xun Zhang, Yun-tian Sun, 2003, Acta Cytologica.

Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.

M. Birrer, K. Darcy, C. Tian, 2009, Gynecologic oncology.

Modern Management of Recurrent Ovarian Carcinoma

C. Michener, J. Belinson, 2005 .

Modern management of recurrent ovarian carcinoma. A systematic approach to a chronic disease.

C. Michener, J. Belinson, 2005, Oncology.

Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.

John D. Roberts, L. Haugh, R. Branda, 1990, Cancer research.

Effect of commercial peritoneal dialysis fluids on the lytic function of lymphokine-activated killer cells.

R. Albertini, J. Stewart, J. Belinson, 1988, Journal of biological response modifiers.

Isolated cervical metastasis of breast cancer: a case report and review of the literature.

C. Michener, C. Biscotti, J. Belinson, 2004, Gynecologic oncology.

Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatin

T. Ashikaga, J. Belinson, I. Krakoff, 1984, Cancer.

Low-dose intravenous ondansetron (8 mg) plus dexamethasone: an effective regimen for the control of carboplatin-induced emesis

M. Markman, J. Belinson, A. Kennedy, 2005, Journal of Cancer Research and Clinical Oncology.

Phase 2 trial of prolonged administration of oral topotecan in platinum/taxane-refractory ovarian, fallopian tube, and primary peritoneal cancers.

M. Markman, J. Belinson, K. Webster, 2004, Gynecologic oncology.

Update on the diagnosis and treatment of human papillomavirus infection.

J. Belinson, K. Zanotti, 2002, Cleveland Clinic journal of medicine.

Primary Cervical Cancer Screening and Triage Using an mRNA Human Papillomavirus Assay and Visual Inspection

J. Belinson, A. Chiesa-Vottero, J. Brainard, 2013, International Journal of Gynecologic Cancer.

Improved sensitivity of vaginal self‐collection and high‐risk human papillomavirus testing

X. Yi, P. Castle, Bin Yang, 2012, International journal of cancer.

Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method

Y. Qiao, P. Castle, Jennifer S. Smith, 2012, Journal of the National Cancer Institute.

Human Papillomavirus Messenger RNA Assay for Cervical Cancer Screening: The Shenzhen Cervical Cancer Screening Trial I

Y. Liu, J. Belinson, S. Belinson, 2010, International Journal of Gynecologic Cancer.

An effective and more convenient drug regimen for prophylaxis gainst paclitaxel-associated hypersensitivity reactions

Maurie Markman, M. Markman, J. Belinson, 1999, Journal of Cancer Research and Clinical Oncology.

Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy.

M. Markman, J. Belinson, A. Kennedy, 2000, Gynecologic oncology.

The effect of cytoxan, adriamycin, and cis-platinum on cervical, vaginal cytology.

J. Belinson, R. Korson, J. Papillo, 1985, Gynecologic oncology.

Patient Acceptance of Self-Sampling for Human Papillomavirus in Rural China

Y. Qiao, J. Belinson, Rui-de Huang, 2003, Journal of lower genital tract disease.

Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening.

P. Rose, F. Simpkins, J. Belinson, 2007, Gynecologic oncology.

Clear Cell Adenocarcinoma Arising in Endometriosis of the Rectovaginal Septum

S. Nordqvist, J. Belinson, A. Ng, 1978, Obstetrics and Gynecology.

Using implementation science to advance cancer prevention in India.

E. Trimble, P. Gupta, R. Mehrotra, 2015, Asian Pacific journal of cancer prevention : APJCP.

Apoptotic pathways induced by ixabepilone in paclitaxel-refractory ovarian carcinoma cells

F. Lee, R. Bukowski, R. Ganapathi, 2005 .

Virilizing malignant lipid cell tumor producing erythropoietin.

J. Belinson, T. Montag, R. E. Murphy, 1984, Gynecologic oncology.

Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma

M. Markman, J. Belinson, A. Kennedy, 1999, Journal of Cancer Research and Clinical Oncology.

Human Papillomavirus DNA Testing for Cervical Cancer Screening

J. Belinson, S. Belinson, 2012, Molecular Diagnosis & Therapy.

Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years

M. Rothberg, Bo Hu, J. Foucher, 2016, Journal of General Internal Medicine.

Fine-needle aspiration cytology in the management of gynecologic cancer.

J. Belinson, R. Korson, J. Papillo, 1981, American journal of obstetrics and gynecology.

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening

J. Belinson, R. Pretorius, H. Du, 2017, Journal of lower genital tract disease.

Papillary clear cell adenocarcinoma of the groin arising from endometriosis.

T. Bauer, K. Marks, J. Belinson, 1999, Clinical orthopaedics and related research.

Psammoma bodies in peritoneal washings.

J. Belinson, R. Korson, J. Papillo, 1982, Acta cytologica.

Risk factors for HPV infection and cervical cancer among unscreened women in a high‐risk rural area of China

Y. Qiao, B. Graubard, M. Forman, 2006, International journal of cancer.

Adjustment to perceived ovarian cancer risk

G. Casey, M. Tamburrino, K. Franco, 2000, Psycho-oncology.

Detection of BRCA1 mutations by the protein truncation test.

H. Anton-Culver, G. Casey, S. Liao, 1995, Human molecular genetics.

Role of the 18:1 Lysophosphatidic Acid–Ovarian Cancer Immunoreactive Antigen Domain Containing 1 (OCIAD1)–Integrin Axis in Generating Late-Stage Ovarian Cancer

R. Ganapathi, C. Michener, J. Belinson, 2010, Molecular Cancer Therapeutics.

Ovarian cancer immuno-reactive antigen domain containing 1 (OCIAD1), a key player in ovarian cancer cell adhesion.

P. Escobar, R. Ganapathi, C. Michener, 2008, Gynecologic oncology.

Risk factors for endometrial hyperplasia and cancer among women with abnormal bleeding.

A. Weber, M. Piedmonte, J. Belinson, 1999, Obstetrics and gynecology.

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.

M. Markman, J. Belinson, A. Kennedy, 1999, Gynecologic oncology.

Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study

S. Flocke, A. Fader, C. Gunderson, 2016, Journal of lower genital tract disease.

Study of the Diagnostic Efficacy of Real-Time Optical Coherence Tomography as an Adjunct to Unaided Visual Inspection With Acetic Acid for the Diagnosis of Preinvasive and Invasive Neoplasia of the Uterine Cervix

Wei Zhang, Chun Wang, Bin Yang, 2009, International Journal of Gynecologic Cancer.

Diagnostic efficacy of optical coherence tomography in the management of preinvasive and invasive cancer of uterine cervix and vulva

P. Escobar, F. Feldchtein, N. Gladkova, 2003, International Journal of Gynecologic Cancer.

Osteosarcoma metastatic to the ovary: a case report and review of the literature.

C. Biscotti, J. Belinson, G. Eltabbakh, 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.

J. Belinson, H. Du, Chun Wang, 2021, Gynecologic oncology.

The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening

Lihui Wei, J. Belinson, H. Du, 2020, Journal of medical screening.

Evaluation of alternately combining HPV viral load and 16/18 genotyping in secondary screening algorithms

J. Belinson, H. Du, R. Wu, 2019, PloS one.

Triage of Women With Negative Cytology and Positive High-Risk HPV: An Analysis of Data From the SHENCCAST II/III Studies

J. Belinson, R. Pretorius, H. Du, 2014, Journal of lower genital tract disease.

Yield and Mode of Diagnosis of Cervical Intraepithelial Neoplasia 3 or Cancer Among Women With Negative Cervical Cytology and Positive High-Risk Human Papillomavirus Test Results

J. Belinson, R. Pretorius, Patricia Peterson, 2013, Journal of lower genital tract disease.

Secondary Screening After Primary Self-Sampling for Human Papillomavirus From SHENCCAST II

Bin Yang, J. Belinson, R. Pretorius, 2012, Journal of lower genital tract disease.

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

Jack Cuzick, Marc Arbyn, J. Cuzick, 2016, Annals of internal medicine.

Cervical Cancer Screening by Simple Visual Inspection After Acetic Acid

Y. Qiao, P. Elson, J. Belinson, 2001, Obstetrics and gynecology.

Serum albumin: its relationship to marrow and renal toxicity from platinum-based combination chemotherapy.

G. Badger, P. Kulig, J. Belinson, 1990, Gynecologic Oncology.

A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus–positive and -Negative Cervical Precancers

J. Cuzick, M. Schiffman, T. Wright, 2020, Cancer Prevention Research.

Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening

Qing Yang, Liming Gui, J. Belinson, 2022, Frontiers in Public Health.

Paraaortic lymphadenectomy in gynecologic cancer.

H. Averette, J. Belinson, M. Goldberg, 1979, Gynecologic oncology.

Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy.

T. Bocklage, J. Belinson, K. Lee, 1992, Gynecologic oncology.

Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening

Yan Liu, M. Schiffman, Lihui Wei, 2020, Infectious agents and cancer.

Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.

J. Stewart, J. Belinson, M. Mcclure, 1985, Gynecologic oncology.

Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix

P. Escobar, J. Smith, F. Feldchtein, 2006, International Journal of Gynecologic Cancer.

The prevalence of HR-HPV infection based on self-sampling among women in China exhibited some unique epidemiologic features: HPV infection of Chinese based on self-sampling.

J. Belinson, H. Du, Chun Wang, 2021, Journal of clinical epidemiology.

Diagnostic Efficacy of Real-Time Optical Coherence Tomography in the Management of Preinvasive and Invasive Neoplasia of the Uterine Cervix

Juan Li, Chun Wang, Bin Yang, 2009, International Journal of Gynecologic Cancer.

Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing

Kanan T. Desai, M. Schiffman, S. de Sanjosé, 2020, Infectious Agents and Cancer.

Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study

Y. Qiao, B. Liu, Jennifer S. Smith, 2013, Cancer Causes & Control.

The development and evaluation of a community based model for cervical cancer screening based on self-sampling.

X. Yi, Jiajia Xu, J. Belinson, 2014, Gynecologic oncology.

Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.

J. Belinson, S. Belinson, 2010, Molecular diagnosis & therapy.

Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study.

D. Zahniser, P. Elson, A. Dawson, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Genotyping for HPV 16 and HPV 18 in women with minor cervical 1 lesions : a systematic review and meta-analysis

J. Cuzick, M. Arbyn, A. Szarewski, 2017 .

The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible.

C. Vallejos, J. Salmerón, K. Levinson, 2013, Gynecologic oncology.

A new automated tumor registry and clinical research system and its application to gynecologic oncology patients.

J. Belinson, M. Mcclure, R. Deutsch, 1987, Gynecologic Oncology.

Peritoneal carcinomatosis: Signs and symptoms

K. Levinson, J. Belinson, 2014 .

Evaluation of a new solid media specimen transport card for high risk HPV detection and cervical cancer prevention.

J. Belinson, K. Maurer, Xiaobo Liu, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Simplified regimen for the prevention of paclitaxel-associated hypersensitivity reactions.

M. Markman, A. Kennedy, J. Belinson, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and sociodemographic correlates of anogenital Human Papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population

S. Subramaniam, Y. Woo, P. Goh, 2021, PloS one.

Letter to the editor concerning Petignat et al.'s "Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis." Gynecol Oncol 2007;105(2): 530-535.

J. Belinson, R. Pretorius, 2007, Gynecologic oncology.

SNIPER: A Novel Assay for Human Papillomavirus Testing Among Women in Guizhou, China

J. Belinson, Wei Zhang, S. Belinson, 2010, International Journal of Gynecologic Cancer.

Coexistent breast and vaginal granulocytic sarcoma.

M. Socinski, W. Ershler, J. Belinson, 1983, Gynecologic oncology.

Surgical Management of Invasive Carcinoma of the Vulva Utilizing A Lower Abdominal Midline Incision

H. Averette, J. Belinson, J. Ford, 1979, Gynecologic Oncology.

Comments on: Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high‐resolution microendoscopy to detect cervical precancer

J. Belinson, R. Pretorius, 2021, International journal of cancer.

Comprehensive control of human papillomavirus infections and related diseases.

M. Plummer, M. Poljak, J. Ferlay, 2013, Vaccine.

Preventive Oncology International: A brief history of HPV self-collected vaginal specimens for cervical cancer screening

Youlin Qiao, J. Belinson, R. Pretorius, 2023, Gynecology and Obstetrics Clinical Medicine.

An evaluation of solid versus liquid transport media for high-risk HPV detection and cervical cancer screening on self-collected specimens

Lihui Wei, Yan Liu, Chao Zhao, 2020, Infectious agents and cancer.

Leuprolide in the treatment of endometrial cancer.

M. Markman, A. Kennedy, J. Belinson, 1997, Gynecologic Oncology.

The Peru Cervical Cancer Prevention Study (PERCAPS): Community-Based Participatory Research in Manchay, Peru

J. Salmerón, K. Levinson, Carolina Abuelo, 2013, International Journal of Gynecologic Cancer.

Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2

Kanan T. Desai, M. Schiffman, S. de Sanjosé, 2020, Infectious agents and cancer.

The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy

Jack Cuzick, Marc Arbyn, Suzanne Belinson, 2013, International journal of cancer.

Evaluation of a new solid media specimen transport card for high risk HPV detection and cervical cancer prevention.

J. Belinson, K. Maurer, Xiaobo Liu, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.

Yan Xu, R. Morton, J. Belinson, 1998, Gynecologic oncology.

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

J. Cuzick, M. Arbyn, A. Szarewski, 2017, Annals of internal medicine.

The development and evaluation of a community based model for cervical cancer screening based on self-sampling.

X. Yi, Jiajia Xu, J. Belinson, 2014, Gynecologic oncology.